The global biopsy devices market is projected to grow from USD 2.63 billion in 2025 to approximately USD 4.89 billion by 2034, at a CAGR of 7.16%. Needle-based biopsy guns led the product segment, while biopsy needles are expected to grow at a CAGR of 8.6%. Hospitals accounted for the largest end-use share, with clinics projected to expand at the fastest rate during the forecast period.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Biopsy Devices Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Biopsy Devices Market Revenue and Volume, by Application
8.1.1. Needle-based Biopsy Guns
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Biopsy Guidance Systems
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Biopsy Forceps
8.1.3.1. Market Revenue and Volume Forecast
8.1.4. Biopsy Needles
8.1.4.1. Market Revenue and Volume Forecast
9.1. Biopsy Devices Market Revenue and Volume, by End Use
9.1.1. Hospitals
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Clinics
9.1.2.1. Market Revenue and Volume Forecast
9.1.3. Others
9.1.3.1. Market Revenue and Volume Forecast
10.1. North America
10.1.1. Market Revenue and Volume Forecast, by Application
10.1.2. Market Revenue and Volume Forecast, by End Use
10.1.3. U.S.
10.1.3.1. Market Revenue and Volume Forecast, by Application
10.1.3.2. Market Revenue and Volume Forecast, by End Use
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Volume Forecast, by Application
10.1.4.2. Market Revenue and Volume Forecast, by End Use
10.2. Europe
10.2.1. Market Revenue and Volume Forecast, by Application
10.2.2. Market Revenue and Volume Forecast, by End Use
10.2.3. UK
10.2.3.1. Market Revenue and Volume Forecast, by Application
10.2.3.2. Market Revenue and Volume Forecast, by End Use
10.2.4. Germany
10.2.4.1. Market Revenue and Volume Forecast, by Application
10.2.4.2. Market Revenue and Volume Forecast, by End Use
10.2.5. France
10.2.5.1. Market Revenue and Volume Forecast, by Application
10.2.5.2. Market Revenue and Volume Forecast, by End Use
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Volume Forecast, by Application
10.2.6.2. Market Revenue and Volume Forecast, by End Use
10.3. APAC
10.3.1. Market Revenue and Volume Forecast, by Application
10.3.2. Market Revenue and Volume Forecast, by End Use
10.3.3. India
10.3.3.1. Market Revenue and Volume Forecast, by Application
10.3.3.2. Market Revenue and Volume Forecast, by End Use
10.3.4. China
10.3.4.1. Market Revenue and Volume Forecast, by Application
10.3.4.2. Market Revenue and Volume Forecast, by End Use
10.3.5. Japan
10.3.5.1. Market Revenue and Volume Forecast, by Application
10.3.5.2. Market Revenue and Volume Forecast, by End Use
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Volume Forecast, by Application
10.3.6.2. Market Revenue and Volume Forecast, by End Use
10.4. MEA
10.4.1. Market Revenue and Volume Forecast, by Application
10.4.2. Market Revenue and Volume Forecast, by End Use
10.4.3. GCC
10.4.3.1. Market Revenue and Volume Forecast, by Application
10.4.3.2. Market Revenue and Volume Forecast, by End Use
10.4.4. North Africa
10.4.4.1. Market Revenue and Volume Forecast, by Application
10.4.4.2. Market Revenue and Volume Forecast, by End Use
10.4.5. South Africa
10.4.5.1. Market Revenue and Volume Forecast, by Application
10.4.5.2. Market Revenue and Volume Forecast, by End Use
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Volume Forecast, by Application
10.4.6.2. Market Revenue and Volume Forecast, by End Use
10.5. Latin America
10.5.1. Market Revenue and Volume Forecast, by Application
10.5.2. Market Revenue and Volume Forecast, by End Use
10.5.3. Brazil
10.5.3.1. Market Revenue and Volume Forecast, by Application
10.5.3.2. Market Revenue and Volume Forecast, by End Use
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Volume Forecast, by Application
10.5.4.2. Market Revenue and Volume Forecast, by End Use
11.1. Medtronic plc
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Becton, Dickinson, and Company
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Hologic, Inc.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Boston Scientific Corporation
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Olympus Corporation
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. C. R. Bard, Inc. (acquired by BD)
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Cook Medical LLC
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. FUJIFILM Holdings Corporation
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Mauna Kea Technologies
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Devicor Medical Products, Inc.
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
13.1. About Us
13.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Get a Sample
Report Description
Get a Sample
Report Description